Literature DB >> 19193114

Efficacy of etravirine for treatment of acute HIV meningoencephalitis.

Carine Couzigou1, Sophie Seang, Laurence Morand-Joubert, Anne-Marie Roque-Afonso, Lélia Escaut, Daniel Vittecoq.   

Abstract

We describe a patient with human immunodeficiency virus (HIV) and hepatitis C virus coinfection who experienced recurrent episodes of acute HIV meningoencephalitis. The addition of etravirine to the therapeutic regimen completely resolved symptoms, and HIV was no longer detected in cerebrospinal spinal fluid specimens. Etravirine has a satisfactory safety profile and, in this case, was a durable alternative therapy for HIV meningoencephalitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19193114     DOI: 10.1086/597109

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  2 in total

Review 1.  Editorial neuroAIDS review.

Authors:  Paul Shapshak; Pandjassarame Kangueane; Robert K Fujimura; Deborah Commins; Francesco Chiappelli; Elyse Singer; Andrew J Levine; Alireza Minagar; Francis J Novembre; Charurut Somboonwit; Avindra Nath; John T Sinnott
Journal:  AIDS       Date:  2011-01-14       Impact factor: 4.177

2.  Etravirine in CSF is highly protein bound.

Authors:  Anh Nguyen; Steven Rossi; David Croteau; Brookie M Best; David Clifford; Ann C Collier; Benjamin Gelman; Christina Marra; Justin McArthur; J Allen McCutchan; Susan Morgello; David Simpson; Ronald J Ellis; Igor Grant; Edmund Capparelli; Scott Letendre
Journal:  J Antimicrob Chemother       Date:  2013-01-20       Impact factor: 5.790

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.